diabetes
Exubera approval limited to needle-phobic patients
January 26, 2007Sales and Marketing Exubera, NICE, Pfizer, diabetes, inhaled insulin
Diabetes patients who are genuinely needle-phobic will be among the few to be given Pfizer’s inhaled insulin product Exubera on …
Byetta receives EU approval for Type II diabetes
November 28, 2006Sales and Marketing diabetes
Lilly and Amylin's new diabetes treatment, Byetta, has won EU approval.It is the first in a new class of anti-diabetic …
Surprise delay for Novartis’ Galvus
November 15, 2006Sales and Marketing Galvus, diabetes
The FDA will take three months longer than expected to review Novartis' new diabetes treatment, Galvus, after the pharma company …
New diabetes drug Byetta set for European approval
September 22, 2006Sales and Marketing Byetta, diabetes
Lilly and Amylin's new diabetes treatment Byetta is set for European approval following recommendation from medicines regulator the EMEA.Byetta (exenatide) …
Pfizer to go it alone with Exubera
January 16, 2006Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin
Pfizer has paid $1.3 billion to buy out its marketing partner’s stake in new inhaled diabetes drug Exubera.The US company …
